Related Experiment Video
Updated: Jan 28, 2026

Live-cell Imaging of Fungal Cells to Investigate Modes of Entry and Subcellular Localization of Antifungal Plant Defensins
Published on: December 24, 2017
The fungal cell wall as a target for the development of new antifungal therapies
Juan Carlos G Cortés1, M-Ángeles Curto1, Vanessa S D Carvalho1
1Instituto de Biología Funcional y Genómica and Departamento de Microbiología y Genética, Consejo Superior de Investigaciones Científicas (CSIC)/Universidad de Salamanca, Salamanca, Spain.
Abstract:
In the past three decades invasive mycoses have globally emerged as a persistent source of healthcare-associated infections. The cell wall surrounding the fungal cell opposes the turgor pressure that otherwise could produce cell lysis. Thus, the cell wall is essential for maintaining fungal cell shape and integrity. Given that this structure is absent in host mammalian cells, it stands as an important target when developing selective compounds for the treatment of fungal infections. Consequently, treatment with echinocandins, a family of antifungal agents that specifically inhibits the biosynthesis of cell wall (1-3)β-D-glucan, has been established as an alternative and effective antifungal therapy. However, the existence of many pathogenic fungi resistant to single or multiple antifungal families, together with the limited arsenal of available antifungal compounds, critically affects the effectiveness of treatments against these life-threatening infections. Thus, new antifungal therapies are required. Here we review the fungal cell wall and its relevance in biotechnology as a target for the development of new antifungal compounds, disclosing the most promising cell wall inhibitors that are currently in experimental or clinical development for the treatment of some invasive mycoses.
Insights
Invasive fungal infections are a growing threat. Targeting the fungal cell wall, essential for fungal integrity and absent in humans, offers a promising strategy for developing new antifungal drugs to combat resistance.
Area of Science:
- Mycology
- Infectious Diseases
- Drug Discovery
Background:
- Invasive mycoses are a significant healthcare-associated infection globally.
- The fungal cell wall is crucial for fungal integrity and absent in mammalian cells, making it an ideal therapeutic target.
- Echinocandins target fungal cell wall biosynthesis but resistance is a growing concern.
Purpose of the Study:
- To review the fungal cell wall as a target for novel antifungal compounds.
- To discuss the challenges posed by antifungal resistance in invasive mycoses.
- To highlight promising cell wall inhibitors in development.
Main Methods:
- Literature review of fungal cell wall structure and function.
- Analysis of current antifungal therapies and resistance mechanisms.
- Survey of experimental and clinical stage antifungal compounds targeting the cell wall.
Main Results:
- The fungal cell wall is essential for fungal survival and a validated target for antifungal drugs.
- Antifungal resistance necessitates the development of new therapeutic strategies.
- Several novel cell wall inhibitors are under investigation for treating invasive fungal infections.
Conclusions:
- The fungal cell wall remains a critical target for developing new antifungal agents.
- Addressing antifungal resistance requires continuous innovation in drug discovery.
- Promising new compounds targeting the cell wall offer hope for improved treatment of invasive mycoses.
More Related Videos
08:29Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System
Published on: October 4, 2024
12:29Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Related Concept Videos
Plant Cell Wall
Plant Cell Wall
Targeted Cancer Therapies
There are several types of targeted therapies against...
Bacterial Cell Wall
Archaeal Cell Wall
Fungal Group Zygomycota